fbpx

Tadalafil — evidence-based review (for informational purposes only)

Disclaimer: This article is for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding personal medical decisions.

Quick summary

  • Tadalafil is a prescription medication used mainly for erectile dysfunction (ED), benign prostatic hyperplasia (BPH), and sometimes pulmonary arterial hypertension (PAH).
  • It belongs to a group of drugs called PDE5 inhibitors and works by improving blood flow in specific tissues.
  • Its effects can last up to 36 hours, which is longer than some similar medications.
  • It is generally effective and well studied, but may cause side effects such as headache, flushing, or indigestion.
  • It should not be used with nitrates or certain heart medications due to the risk of severe low blood pressure.

What is known

What tadalafil is and how it works

Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor. PDE5 is an enzyme that breaks down a molecule called cyclic guanosine monophosphate (cGMP). cGMP helps relax smooth muscle and widen blood vessels. By blocking PDE5, tadalafil increases cGMP levels, leading to improved blood flow.

In erectile dysfunction, this improved blood flow helps achieve and maintain an erection during sexual stimulation. In benign prostatic hyperplasia, it may relax smooth muscle in the prostate and bladder, improving urinary symptoms. In pulmonary arterial hypertension, it helps widen blood vessels in the lungs, reducing pressure.

Effectiveness in erectile dysfunction (ED)

Multiple randomized controlled trials and meta-analyses show that tadalafil significantly improves erectile function compared with placebo. It has been studied in men with different causes of ED, including diabetes, cardiovascular disease, and post-prostate surgery.

One distinctive feature is its longer duration of action (up to 36 hours), which allows for more spontaneity compared with shorter-acting PDE5 inhibitors. Clinical guidelines from organizations such as the American Urological Association (AUA) consider PDE5 inhibitors, including tadalafil, first-line therapy for ED in many men.

Effectiveness in benign prostatic hyperplasia (BPH)

Tadalafil is also approved in many countries for urinary symptoms due to BPH. Clinical trials show modest but meaningful improvements in symptom scores compared with placebo. It may be particularly useful in men who have both ED and BPH.

Use in pulmonary arterial hypertension (PAH)

Under specific brand names and dosing regimens, tadalafil is approved for PAH. Studies demonstrate improved exercise capacity and delayed clinical worsening. In this context, treatment is usually supervised by specialists.

Safety and side effects

Common side effects include:

  • Headache
  • Facial flushing
  • Indigestion (dyspepsia)
  • Back pain or muscle aches
  • Nasal congestion

Most side effects are mild to moderate and temporary. Rare but serious risks include sudden vision or hearing changes and prolonged erections (priapism), which require urgent medical attention.

Tadalafil must not be combined with nitrates (often used for chest pain) because this combination can cause a dangerous drop in blood pressure. Caution is also needed in people with certain heart conditions, severe liver or kidney disease, or those taking specific medications that affect drug metabolism.

What is unclear / where evidence is limited

  • Long-term outcomes beyond symptom control: While tadalafil improves symptoms of ED and BPH, evidence that it changes long-term disease progression is limited.
  • Comparative superiority: Although tadalafil lasts longer, evidence does not clearly show it is universally “better” than other PDE5 inhibitors; individual response varies.
  • Use in complex medical cases: Data are more limited in patients with multiple severe chronic conditions or advanced cardiovascular disease, who are often underrepresented in trials.
  • Psychological outcomes: Improvements in quality of life are reported, but the degree to which tadalafil alone addresses psychological components of sexual dysfunction is variable.

Overview of approaches

Management depends on the condition being treated (ED, BPH, or PAH) and underlying health factors.

  • Erectile dysfunction: PDE5 inhibitors such as tadalafil are commonly considered first-line therapy, alongside lifestyle changes and management of underlying conditions (e.g., diabetes, hypertension).
  • Benign prostatic hyperplasia: Options include alpha-blockers, 5-alpha-reductase inhibitors, combination therapy, and in some cases tadalafil.
  • Pulmonary arterial hypertension: Treated in specialized centers with medications including PDE5 inhibitors, endothelin receptor antagonists, and others.

Typical dosing information for approved uses can be found in official prescribing information from regulatory agencies such as the U.S. Food and Drug Administration (FDA):
FDA prescribing information for Cialis (tadalafil).
Dosing varies by indication and individual factors; patients should follow their clinician’s instructions.

For a broader understanding of sexual health and related conditions, see our overview on erectile dysfunction basics and men’s urological health. If urinary symptoms are present, our page on benign prostatic hyperplasia explained may also be helpful.

Table: Key statements and level of confidence

Statement Confidence level Why
Tadalafil improves erectile function compared with placebo. High Supported by multiple randomized trials and clinical guidelines.
Tadalafil improves urinary symptoms in BPH. High Backed by controlled trials and regulatory approval for this indication.
Tadalafil is superior to all other PDE5 inhibitors. Low Comparative studies show similar efficacy; differences mainly in duration and side-effect profile.
Tadalafil modifies long-term disease progression in ED or BPH. Low to medium Evidence mainly supports symptom control, not clear disease modification.
Combining tadalafil with nitrates is dangerous. High Well-documented pharmacologic interaction with risk of severe hypotension.

Practical recommendations

General safety measures

  • Use tadalafil only if prescribed by a licensed healthcare professional.
  • Inform your doctor about all medications and supplements you take, especially heart medications.
  • Avoid buying medications from unverified online sources due to the risk of counterfeit products.
  • Adopt heart-healthy lifestyle habits (regular exercise, balanced diet, smoking cessation), which can improve both erectile and cardiovascular health.

When to see a doctor

  • If you experience chest pain, fainting, or severe dizziness.
  • If you have an erection lasting more than 4 hours (medical emergency).
  • If you notice sudden loss of vision or hearing.
  • If erectile dysfunction is new, worsening, or accompanied by other symptoms (it may signal cardiovascular disease).

How to prepare for a consultation

  • List current medications and medical conditions.
  • Be ready to discuss cardiovascular history and risk factors.
  • Describe symptoms clearly (onset, severity, frequency).
  • Note any psychological stressors or relationship factors that may be relevant.

For more general medical topics, you may explore our section in Sin categoría, where we review health conditions in plain language.

Sources

  • American Urological Association (AUA). Erectile Dysfunction Guideline.
  • European Association of Urology (EAU). Guidelines on Sexual and Reproductive Health.
  • U.S. Food and Drug Administration (FDA). Prescribing Information for Cialis (tadalafil): https://www.accessdata.fda.gov/
  • National Institutes of Health (NIH). MedlinePlus: Tadalafil.
  • European Medicines Agency (EMA). Tadalafil product information.